- 专利标题： LAMOTRIGINE ORAL LIQUID SUSPENSION AND USE THEREOF
-
申请号： US18752293申请日： 2024-06-24
-
公开(公告)号： US20240342183A1公开(公告)日： 2024-10-17
- 发明人: Paul Sudhakar , Scott Boyer
- 申请人： OWP Pharmaceuticals, Inc.
- 申请人地址： US IL Naperville
- 专利权人： OWP Pharmaceuticals, Inc.
- 当前专利权人： OWP Pharmaceuticals, Inc.
- 当前专利权人地址： US IL Naperville
- 主分类号： A61K31/53
- IPC分类号： A61K31/53 ; A61K9/00 ; A61K47/02 ; A61K47/06 ; A61K47/10 ; A61K47/26 ; A61K47/34 ; A61K47/36 ; A61K47/38
摘要：
The present invention relates to an oral liquid suspension that includes lamotrigine and methods of medical treatment that include administering the oral liquid suspension. The oral liquid suspension has desirable physicochemical properties and technical attributes. The oral liquid suspension is useful in patients having difficulties in swallowing tablets and provide medical practitioners with additional options for dose titration.
信息查询
